Remedy | Weight Watchers should still profit from dieters ‘getting their guts out’ after taking Ozempic: Analyst
Weight Watchers’ inventory has taken successful with the rise of weight-loss medicine — however the firm may nonetheless profit from members who’re “getting their guts out” after taking medicine like Ozempic, Wall Avenue analysts say. In line with.
Shares of WW Worldwide fell 25 % on Thursday after Oprah Winfrey stated she was leaving the food regimen firm’s board to “remove any perceived battle of curiosity about taking weight-loss medicine.” have been” – a reality she admitted final yr amid widespread hypothesis about her slimming down. Determine under
Though Winfrey’s exit has raised questions in regards to the relevance of WeightWatchers, weight-loss sufferers nonetheless “want recommendation about once they overeat at a restaurant and now get their guts out.” have been” due to the uncomfortable side effects of medicine like Ozempic or Wegovy, in keeping with DA Davidson analyst Linda Bolton Weiser.
“They want recommendation on what to do with their extra pores and skin as soon as they’ve misplaced 100 kilos,” Bolton Weiser wrote in a analysis observe to purchasers on Monday. “That is why an investor would purchase Weight Watchers as a substitute of Eli Lilly or Nordisk.”
Bolton Weiser has a “Purchase” ranking by Weight Watchers and a value goal of $12.50.
Shares of Weight Watchers fell 3.8% to $3.25 on Monday — down 53% from $7 a yr in the past and 83% since a peak of $13.21 in October.
Bolton Weiser stated she was responding to a junior analyst who questioned, “Why would an investor be fascinated by investing in Weight Watchers, which prescribes a weight-loss drug, once they make the drug? One can spend money on Eli Lilly or Nordisk.[s],’ in keeping with the observe.
Shares of the New York-based firm have been falling for the previous yr as food regimen medicine have gone mainstream and legacy food regimen manufacturers like Weight Watchers have gone mainstream.
A yr in the past, WeightWatchers paid $106 million to amass Sequence, a telehealth subscription service that prescribes Ozempic and different weight-loss medicine.
The corporate’s chief government, Seema Sistani, stated on an earnings name final week that Weight Watchers is specializing in offering “care” to new clients taking food regimen medicine, together with prescription service and entry to Weight Watchers clinics. Pay $100 a month. .
“We will market proper now. . . speaking to the truth that what we’re providing is nice care and a membership that may assist them with their weight well being,” Sistani stated final week. stated on an earnings name final week wherein he used the phrase ‘care’ 19 instances.
In the meantime, Winfrey’s affiliation with Weight Watchers ended final week after a nine-year run when her shares rose each time she posted a message on her social media accounts about her weight reduction or consuming habits. going
Over the summer season, Winfrey lowered her stake within the firm from almost 10% to simply 1.4%.
Associated Search Question:-
Remedy updates
new medicine listing
fda drug warnings listing
fda drug alerts
drug remedy examples
what’s drug alert
new medicines
new drug analysis articles
new drug identify
new fda authorised medicine
new drug information
new medicine authorised by cdsco
fda-approved medicine listing
fda approvals right this moment
fda approval listing
drug alerts 2024
fda drug recall 2024
fda drug security tips
medicine@fda
fda drug alerts
fda drug security communication
current medicine recollects
fda.gov/medicine/drug security/drug recollects eye drops
fda complement warning listing
fda banned dietary supplements listing 2024
fda authorised dietary supplements listing
fda banned dietary supplements listing 2024
fda dietary complement ingredient advisory listing
fda warning letters dietary dietary supplements
fda drug warnings listing
fda warning letter database
fda warning letters 2024
#Weight #Watchers #profit #dieters #guts #Ozempic #Analyst
